LONDON, Feb. 27 -- The government of the United Kingdom issued the following news:
AnMHRA spokesperson said:
"Withallclinical trials,theMHRA's top priority is the safety and wellbeing of the trial participants. As part of that commitment,complexclinical trialsarekept continuously under review andtheMHRA maintainsan active scientific dialogue with trial sponsors.
"The MHRA has world-class medical, scientific, and regulatory experts who work as a multidisciplinary team to provide evidence-based decisions on clinical trials. These experts will continue to meet with King's College London to work through the next steps constructively.
"Following the identification of social media posts made prior to his appointment, Professor Jacob George is recused from further involvement on the Pathways clinical trial as a precaution."
Disclaimer: Curated by HT Syndication.
